Goodwin Advises Pharmakon Advisors on Intellectual Property Aspects for CHF 250 Million ($310 Million USD) Loan to Idorsia Pharmaceuticals Ltd
June 10, 2026
June 10, 2026
BOSTON, Massachusetts, June 10 [Category: BizLaw/Legal] -- Goodwin, a law firm, issued the following news release:
* * *
Goodwin Advises Pharmakon Advisors on Intellectual Property Aspects for CHF 250 Million ($310 Million USD) Loan to Idorsia Pharmaceuticals Ltd
*
The Intellectual Property team advised Pharmakon Advisors, LP, on IP aspects associated with entering into a senior secured term loan agreement of up to CHF 250 million ($310 million . . .
* * *
Goodwin Advises Pharmakon Advisors on Intellectual Property Aspects for CHF 250 Million ($310 Million USD) Loan to Idorsia Pharmaceuticals Ltd
*
The Intellectual Property team advised Pharmakon Advisors, LP, on IP aspects associated with entering into a senior secured term loan agreement of up to CHF 250 million ($310 million . . .
